07.04.2014 • NewsbiopharmaceuticalsDede WillamsMerck

Merck Serono Gains Rights to Market EEVA Test

Merck Serono, the Swiss-based biopharmaceutical division of Germany's Merck KGaA, has signed an exclusive license agreement with U.S. reproductive medicine specialist Auxogyn of Menlo Park, California to help commercialize Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

Financial details of the arrangement were not disclosed. Under its terms, Merck Serono will obtain exclusive rights to commercialize the test in Europe and Canada, with the option to extend to selected countries and regions. Auxogyn will retain exclusive rights in the U.S. market. 

Merck Serono's relationship with Auxogyn dates to 2012 when its corporate venture capital fund, MS Ventures, sealed a strategic partnership with the California company on the Eeva Test.

Used adjunctively to traditional morphology, the non-invasive diagnostic tool utilizes time-lapse imaging and computer software to help reproductive endocrinologists and embryologists assess embryo development and viability.

The new agreement further underscores the company's commitment to fertility treatment, said Dorothea Wenzel, head of the global business franchise Fertility at Merck Serono. Employing Merck's established commercial expertise will accelerate the availability of the Eeva Test in key international markets, added Lissa Goldenstein, president and CEO of Auxogyn.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.